Alterations in the human oral and gut microbiomes and lipidomics in COVID-19
- PMID: 33789966
- PMCID: PMC8042598
- DOI: 10.1136/gutjnl-2020-323826
Alterations in the human oral and gut microbiomes and lipidomics in COVID-19
Abstract
Objective: To characterise the oral microbiome, gut microbiome and serum lipid profiles in patients with active COVID-19 and recovered patients; evaluate the potential of the microbiome as a non-invasive biomarker for COVID-19; and explore correlations between the microbiome and lipid profile.
Design: We collected and sequenced 392 tongue-coating samples, 172 faecal samples and 155 serum samples from Central China and East China. We characterised microbiome and lipid molecules, constructed microbial classifiers in discovery cohort and verified their diagnostic potential in 74 confirmed patients (CPs) from East China and 37 suspected patients (SPs) with IgG positivity.
Results: Oral and faecal microbial diversity was significantly decreased in CPs versus healthy controls (HCs). Compared with HCs, butyric acid-producing bacteria were decreased and lipopolysaccharide-producing bacteria were increased in CPs in oral cavity. The classifiers based on 8 optimal oral microbial markers (7 faecal microbial markers) achieved good diagnostic efficiency in different cohorts. Importantly, diagnostic efficacy reached 87.24% in the cross-regional cohort. Moreover, the classifiers successfully diagnosed SPs with IgG antibody positivity as CPs, and diagnostic efficacy reached 92.11% (98.01% of faecal microbiome). Compared with CPs, 47 lipid molecules, including sphingomyelin (SM)(d40:4), SM(d38:5) and monoglyceride(33:5), were depleted, and 122 lipid molecules, including phosphatidylcholine(36:4p), phosphatidylethanolamine (PE)(16:0p/20:5) and diglyceride(20:1/18:2), were enriched in confirmed patients recovery.
Conclusion: This study is the first to characterise the oral microbiome in COVID-19, and oral microbiomes and lipid alterations in recovered patients, to explore their correlations and to report the successful establishment and validation of a diagnostic model for COVID-19.
Keywords: COVID-19; intestinal microbiology; lipid metabolism.
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
Similar articles
-
Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma.Gut. 2019 Jun;68(6):1014-1023. doi: 10.1136/gutjnl-2017-315084. Epub 2018 Jul 25. Gut. 2019. PMID: 30045880 Free PMC article.
-
Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19.Gut. 2021 Feb;70(2):276-284. doi: 10.1136/gutjnl-2020-322294. Epub 2020 Jul 20. Gut. 2021. PMID: 32690600 Free PMC article.
-
Characterization of oral and gut microbiome and plasma metabolomics in COVID-19 patients after 1-year follow-up.Mil Med Res. 2022 Jun 17;9(1):32. doi: 10.1186/s40779-022-00387-y. Mil Med Res. 2022. PMID: 35715833 Free PMC article.
-
The gut microbiome: a missing link in understanding the gastrointestinal manifestations of COVID-19?Cold Spring Harb Mol Case Stud. 2021 Apr 8;7(2):a006031. doi: 10.1101/mcs.a006031. Print 2021 Apr. Cold Spring Harb Mol Case Stud. 2021. PMID: 33593727 Free PMC article. Review.
-
Regional Diversity of the Gastrointestinal Microbiome.Cell Host Microbe. 2019 Sep 11;26(3):314-324. doi: 10.1016/j.chom.2019.08.011. Cell Host Microbe. 2019. PMID: 31513770 Free PMC article. Review.
Cited by
-
Characterization of the gut microbiota in patients with SARS-CoV-2 infection during controlled ovarian stimulation.J Ovarian Res. 2024 Nov 20;17(1):231. doi: 10.1186/s13048-024-01553-7. J Ovarian Res. 2024. PMID: 39568001 Free PMC article.
-
The Multiple Challenges of Nutritional Microbiome Research During COVID-19-A Perspective and Results of a Single-Case Study.Nutrients. 2024 Oct 30;16(21):3693. doi: 10.3390/nu16213693. Nutrients. 2024. PMID: 39519526 Free PMC article.
-
Impact of Mild COVID-19 History on Oral-Gut Microbiota and Serum Metabolomics in Adult Patients with Crohn's Disease: Potential Beneficial Effects.Biomedicines. 2024 Sep 14;12(9):2103. doi: 10.3390/biomedicines12092103. Biomedicines. 2024. PMID: 39335616 Free PMC article.
-
A six-year study in a real-world population reveals an increased incidence of dyslipidemia during COVID-19.J Clin Invest. 2024 Sep 12;134(21):e183777. doi: 10.1172/JCI183777. J Clin Invest. 2024. PMID: 39264723 Free PMC article.
-
Large-scale genetic correlation studies explore the causal relationship and potential mechanism between gut microbiota and COVID-19-associated risks.BMC Microbiol. 2024 Aug 5;24(1):292. doi: 10.1186/s12866-024-03423-0. BMC Microbiol. 2024. PMID: 39103761 Free PMC article.
References
-
- WHO . Coronavirus disease (COVID-19) Weekly epidemiological update and Weekly operational update, 2020. Available: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situatio...
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials